Clinical Trials

132 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms

NCT05237349 2024-01-05

Envafolimab Combined With Chemotherapy in Metastatic or Recurrent Gastric Adenocarcinoma

38 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT06170697 2023-12-20

Advanced First-line Treatment of Short-term Postoperative Progression of Head and Neck Squamous Cell Carcinoma

46 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT03620032 2023-12-06

DIPG

54 enrolled

CNS

Diffuse Intrinsic Pontine Glioma

NCT05935579 2023-11-15

Durvalumab and Lenvatinib With or Without Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer

40 enrolled

Biliary Tract Neoplasms

NCT06120127 2023-11-07

IMPROVE

Colorectal Neoplasms

NCT03742193 2023-11-01

PROACH

43 enrolled

Sarcoma

Osteosarcoma

NCT05128630 2023-09-28

DEDALUS

45 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04681287 2023-09-25

Exploratory Study of Advanced Breast Cancer in HER2 Positive Patients With Failure of Multi-line Therapy Treated by Combination of Inetetamab (Cipterbin) + PD-1 Inhibitor Combined With Utidelone.

46 enrolled

Breast

HER2 Positive Metastatic Breast Cancer

NCT04653480 2023-07-17

Surufatinib, Toripalimab and Chemotherapy in Second-line MT and MSS CRC

61 enrolled

Colorectal Neoplasms

NCT02679040 2023-07-03

HIST-RIC

101 enrolled

Breast

Breast Neoplasms

NCT05868317 2023-05-22

Induction Chemotherapy Followed by Short Course Radiotherapy in Rectal Cancer

70 enrolled

Rectal Neoplasms

NCT05844371 2023-05-06

Efficacy and Safety of Tirelizumab Plus Chemotherapy Versus Chemotherapy Alone in Patients With Lymph Node Positive Gastric Cancer After Surgery

60 enrolled

Stomach Neoplasms

NCT05842018 2023-05-03

Toripalimab in Combination With Chemotherapy and Antiangiogenic Agents in Patients With Non-Small Cell Lung Cancer After Failure of Immunotherapy (PD-1/L1 Inhibitors)

Non Small Cell Lung Cancer Recurrent

NCT04667793 2023-04-04

Clinical Study of Neoadjuvant PD-1 Antibody (Toripalimab) Plus Chemotherapy for Locally Advanced Thymic Epithelial Tumor

15 enrolled

Thymic epithelial tumor

NCT03975114 2023-03-24

MILES-5

460 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05541146 2023-03-23

Intraperitoneal Chemotherapy in Gastric Cancer With Peritoneal Carcinomatosis

GastrointestinalGynecologic

Carcinoma, Peritoneal Neoplasms, Stomach Neoplasms

NCT03803436 2023-03-16

COLT

22 enrolled

Liver Neoplasms, Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT05549466 2023-02-08

Targeted or Chemotherapy Combined With Immunotherapy Versus Chemotherapy for PD-1 Inhibitor Refractory R/M NPC

84 enrolled

Nasopharyngeal Carcinoma

NCT05650216 2022-12-14

Camrelizumab Combined With Neoadjuvant Concurrent Chemoradiotherapy for Resectable Locally Advanced ESCC（NICE-RT）

50 enrolled

Esophageal Squamous Cell Carcinoma

NCT05437692 2022-10-12

Zimberelimab Combined With Concurrent Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer

19 enrolled

Locally Advanced Cervical Cancer

NCT05575635 2022-10-12

Neoadjuvant Treatment of Fruquintinib Combined With Concurrent Chemoradiotherapy for LARC

40 enrolled

Rectal Neoplasms

NCT05422183 2022-06-16

Envafolimab, Lenvatinib Combined With VP-16 in Platinum-resistant Recurrent Epithelial Ovarian Cancer

20 enrolled

Carcinoma, Ovarian Epithelial

NCT05399394 2022-06-01

FOLRT

50 enrolled

Pancreatic Neoplasms

NCT05360979 2022-05-04

A Clinical Study of Immunotherapy Combined With Chemotherapy and Anti-angiogenic Therapy in Operable NSCLC

42 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05311189 2022-04-05

Study of HLX10, Trastuzumab and Chemotherapy in First-line Treatment of HER2-positive Recurrent/Metastatic Gastric Cancer

40 enrolled

HER2-positive Gastric Cancer

NCT05298020 2022-03-28

Envafolimab Combined With Endostar and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer

20 enrolled

Advanced Pancreatic Cancer

NCT05243355 2022-02-17

Envafolimab Combined With Chemotherapy and Recombinant Human Endostatin in the First-line Treatment of Sq-NSCLC

46 enrolled

Squamous Non-small Cell Lung Cancer

NCT05241132 2022-02-15

Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown Primary

27 enrolled

Tumor-Agnostic

Neoplasms

NCT05183958 2022-01-11

A Multicenter, Randomized Controlled, Phase II Clinical Study of First-line Chemotherapy and Camrelizumab With or Without Radiotherapy in the Treatment of Oligometastatic Esophageal Cancer

118 enrolled

Esophageal Neoplasms

NCT05184946 2022-01-11

Clinical Study of Camrelizumab Combined With SOX in the Adjuvant Treatment of Advanced Gastric Adenocarcinoma or Gastric Esophageal Junction Adenocarcinoma

72 enrolled

Stomach Neoplasms

NCT05174325 2021-12-30

Effectiveness of Neoadjuvant Chemotherapy Combined With PD-1 Monoclonal Antibody in the Treatment of Operable Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma

NCT05170581 2021-12-28

Clinical Study of Sintilimab Combined With Chemotherapy in Neoadjuvant Treatment of Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT05170594 2021-12-28

A Study of Bevacizumab Combined With Fluzoparib/Chemotherapy or Fluzoparib in the Treatment of Ovarian Cancer

60 enrolled

Ovarian Neoplasms

NCT05136768 2021-11-29

LM-HNSCC

50 enrolled

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis

NCT04275986 2021-07-07

Concurrent Chemoradiotherapy After Endoscopic Resection for Stage I Esophageal Carcinoma

56 enrolled

Esophageal Squamous Cell Carcinoma

NCT01676259 2021-07-02

PROTACT

Neoplasms, Pancreatic Neoplasms

NCT04888806 2021-05-17

A Trial of Camrelizumab Combined With Microwave Ablation and Chemotherapy in the Treatment of Colorectal Cancer Liver Metastasis/Pulmonary Metastasis

37 enrolled

Colorectal Cancer Metastatic

NCT04136600 2020-12-30

EGFR Monoclonal Antibody for Advanced Gastric Cancer

Stomach Neoplasms

NCT04635956 2020-11-19

Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas

20 enrolled

Uterine Cervical Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT04602013 2020-10-26

Sintilimab Injection Combined With Concurrent CCRT in Locally Advanced Esophageal Squamous Cell Carcinoma

53 enrolled

Esophageal Squamous Cell Carcinoma

NCT03989830 2020-10-23

SLICER

53 enrolled

Head and Neck Neoplasms

NCT04559308 2020-09-22

The Effect of Metformin on Breast Cancer Patients

Breast

Breast Neoplasms

NCT01567202 2020-09-09

Study of DC Vaccination Against Glioblastoma

CNS

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms

NCT03267654 2020-08-03

Gefitinib With Chemotherapy or Anti-angiogenesis in NSCLC Patients With Bim Deletion or Low EGFR Mutation Abundance

Carcinoma, Non-Small-Cell Lung

NCT04333927 2020-06-23

ACCORD

92 enrolled

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

NCT04345770 2020-04-14

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer

Stomach Neoplasms

NCT04319874 2020-03-30

Phase II Clinical Trial Scheme of Ganoderma Lucidum Spore Powder for Postoperative Chemotherapy of Osteosarcoma

Sarcoma

Osteosarcoma

NCT04319471 2020-03-24

Sufficient Chemotherapy Combine With Maintenance Chemotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma

70 enrolled

Nasopharyngeal Carcinoma

NCT00798811 2020-03-19

High-dose Chemotherapy With Autologous Stem Cell Rescue in Pediatric High-risk Brain Tumors